Advanced Medical Solutions Group plc (AIM:AMS)

Market Cap	427.90M
Revenue (ttm)	177.52M
Net Income (ttm)	7.09M
Shares Out	217.87M
EPS (ttm)	0.03
PE Ratio	60.43
Forward PE	15.29
Dividend	0.03 (1.32%)
Ex-Dividend Date	May 29, 2025

Volume	773,193
Average Volume	1,063,215
Open	198.00
Previous Close	196.40
Day's Range	197.60 - 207.50
52-Week Range	176.60 - 275.83
Beta	0.69
RSI	45.08
Earnings Date	Mar 19, 2025

About AIM:AMS

Advanced Medical Solutions Group plc, together with its subsidiaries, develops, manufactures, and distributes products for the surgical, woundcare, and wound-closure markets in the United Kingdom, Germany, rest of Europe, the United States, and internationally. It operates in two segments, Surgical and Woundcare. The company offers surgical products, such as tissue adhesives, sutures, haemostats, internal fixation devices, and internal sealants under LiquiBand, RESORBA, LiquiBandFix8, LIQUIFIX, and Seal-G brand names. It also provides wound car...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1991
• Employees: 850
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: AMS

Financial Performance

In 2024, AIM:AMS's revenue was 177.52 million, an increase of 40.66% compared to the previous year's 126.21 million. Earnings were 7.09 million, a decrease of -55.35%.